Ustekinumab-aekn
- Product NDC
- 51759-710
- 11-digit product format
- 517590710
- Labeler code
- 51759
- Product ID
- 51759-710_1577b43b-65ee-4da4-9821-338d1651d3d7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ustekinumab-aekn
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- BLA761343
- Marketing category
- BLA
- Marketing start
- 2025-06-02
- Substance
- USTEKINUMAB-AEKN
- Active strength
- 90 mg/mL
- Pharmacologic classes
- Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51759-710-32 | 51759071032 | 1 TRAY in 1 CARTON (51759-710-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS | 1 tray | 2025-06-02 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Ustekinumab-aekn | Teva Pharmaceuticals USA, Inc. | 2025-12-03 | HUMAN PRESCRIPTION DRUG LABEL | 9 |